Read more about the article Andira Pharmaceuticals’ US Patent Allowed in Breakthrough Therapeutic Treatment to Address Deadly Antibiotic-Resistant Infections
put a patented stamp on document. intellectual property protection
Uncategorized

Andira Pharmaceuticals’ US Patent Allowed in Breakthrough Therapeutic Treatment to Address Deadly Antibiotic-Resistant Infections

Opportunity to invest in Canadian health science firm pioneering a new generation of patented therapeutics for drug-resistant infection is now open globally to eligible investors. SAN FRANCISCO, AUGUST 2023 –…

Comments Off on Andira Pharmaceuticals’ US Patent Allowed in Breakthrough Therapeutic Treatment to Address Deadly Antibiotic-Resistant Infections
August 14, 2023